Effect of different methods of auricular point stimulation on chemotherapy-induced nausea and vomiting and appetite in patients receiving platinum-based chemotherapy
Not Applicable
Recruiting
- Conditions
- chemotherapy-induced nausea and vomiting
- Registration Number
- ITMCTR2200006654
- Lead Sponsor
- Affiliated Hospital of Nanjing University of Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1. Pathologically confirmed diagnosis of malignant tumor; 2. Aged 18-75 years old; 3. Receiving cisplatin chemotherapy; 4. KPS score = 60 points; 5. Expected survival = 6 months; 6. Identify their own disease and agree to participate in this study and sign informed consent.
Exclusion Criteria
1. Patients with concurrent chemoradiotherapy; 2. Patients with coagulation dysfunction or platelet abnormalities; 3. Patients with auricular skin ulceration or allergy to adhesive plaster; 4. Patients with nausea and vomiting caused by intestinal obstruction and other reasons; 5. Patients who are receiving other antiemetic drugs except this trial and cannot determine the efficacy.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Abbreviated Nutritional Appetite Assessment Scale (SNAQ);Chinese MASCC Antiemetic Assessment Tool (MAT Scale);
- Secondary Outcome Measures
Name Time Method ausea and Vomiting Life Function Index (FLIE);